as on January 7, 2026 at 2:29 am IST
Day's High
9.37%
Upside
52 Week's Low
52 Week's High
21.88%
Downside
578.12%
Upside
Check Reviva Pharmaceuticals Holdings market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$38.7M
EPS (TTM)
-0.3333
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-10.1M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-916.17%
Compare market cap, revenue, PE, and other key metrics of Reviva Pharmaceuticals Holdings with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $38.7M | -96.54% | NA | 0.00% | |
| BUY | $37.3B | 414.46% | -16.34 | -264.83% | |
| BUY | $52.6B | 191.54% | 1243.22 | 1.36% | |
| BUY | $115.1B | 101.11% | 31.54 | 31.35% | |
| BUY | $80.9B | 61.38% | 18.28 | 32.13% |
The Reviva Pharmaceuticals Holdings stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Reviva Pharmaceuticals Holdings investment value today
Current value as on today
₹21,172
Returns
Returns from Reviva Pharmaceuticals Holdings Stock
Dollar Returns*
₹5,172 (+5.17%)
Based on 11 analysts
90.91%
Buy
9.09%
Hold
0.00%
Sell
Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Reviva Pharmaceuticals Holdings. Average target price of $4.81
Get share price movements and forecasts by analysts on Reviva Pharmaceuticals Holdings.
What analysts predicted
93.35%UPSIDE
Target Price
$4.81
Current Price
$0.32
Analyzed by
11 Analysts
Target
$4.81
Reviva Pharmaceuticals Holdings target price $4.81, a slight upside of 93.35% compared to current price of $0.32. According to 11 analysts rating.
Investment in Reviva Pharmaceuticals Holdings Shares on INDmoney has grown by 194.44% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:194.44% versus previous 30 day period
Search interest for Reviva Pharmaceuticals Holdings Stock has increased by 35% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:35% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, RVPH stock has moved up by 15.8%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 164.8% return, outperforming this stock by 248.6%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 846.3% return, outperforming this stock by 938.1%
| Organisation | Reviva Pharmaceuticals Holdings |
| Headquarters | 10080 N. Wolfe Road, Cupertino, CA, United States, 95014 |
| CEO | Dr. Laxminarayan Bhat Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Laxminarayan Bhat Ph.D. | Founder, CEO, President & Director |
Mr. Narayan Prabhu | Chief Financial Officer |
Reviva Pharmaceuticals Holdings share price today is $0.32 as on at the close of the market. Reviva Pharmaceuticals Holdings share today touched a day high of $0.35 and a low of $0.32.
Reviva Pharmaceuticals Holdings share touched a 52 week high of $2.17 on and a 52 week low of $0.25 on . Reviva Pharmaceuticals Holdings stock price today i.e. is closed at $0.32,which is 85.25% down from its 52 week high and 28.00% up from its 52 week low.
Reviva Pharmaceuticals Holdings market capitalisation is $0.00T as on .
Indian investors can start investing in Reviva Pharmaceuticals Holdings (RVPH) shares with as little as ₹90.143 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹901.43 in Reviva Pharmaceuticals Holdings stock (as per the Rupee-Dollar exchange rate as on ).
Based on Reviva Pharmaceuticals Holdings share’s latest price of $0.32 as on January 7, 2026 at 2:29 am IST, you will get 31.2500 shares of Reviva Pharmaceuticals Holdings. Learn more about
fractional shares .
Reviva Pharmaceuticals Holdings stock has given -96.54% share price returns and 23.38% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?